Cargando…
N-Acetyl-cysteine causes analgesia by reinforcing the endogenous activation of type-2 metabotropic glutamate receptors
BACKGROUND: Pharmacological activation of type-2 metabotropic glutamate receptors (mGlu2 receptors) causes analgesia in experimental models of inflammatory and neuropathic pain. Presynaptic mGlu2 receptors are activated by the glutamate released from astrocytes by means of the cystine/glutamate anti...
Autores principales: | Bernabucci, Matteo, Notartomaso, Serena, Zappulla, Cristina, Fazio, Francesco, Cannella, Milena, Motolese, Marta, Battaglia, Giuseppe, Bruno, Valeria, Gradini, Roberto, Nicoletti, Ferdinando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3543227/ https://www.ncbi.nlm.nih.gov/pubmed/23088864 http://dx.doi.org/10.1186/1744-8069-8-77 |
Ejemplares similares
-
Analgesia induced by the epigenetic drug, L-acetylcarnitine, outlasts the end of treatment in mouse models of chronic inflammatory and neuropathic pain
por: Notartomaso, Serena, et al.
Publicado: (2017) -
N-acetyl-cysteine, a drug that enhances the endogenous activation of group-II metabotropic glutamate receptors, inhibits nociceptive transmission in humans
por: Truini, Andrea, et al.
Publicado: (2015) -
Pharmacological enhancement of mGlu1 metabotropic glutamate receptors causes a prolonged symptomatic benefit in a mouse model of spinocerebellar ataxia type 1
por: Notartomaso, Serena, et al.
Publicado: (2013) -
Perineuronal nets are under the control of type-5 metabotropic glutamate receptors in the developing somatosensory cortex
por: Mascio, Giada, et al.
Publicado: (2021) -
Targeting type-2 metabotropic glutamate receptors to protect vulnerable hippocampal neurons against ischemic damage
por: Motolese, Marta, et al.
Publicado: (2015)